Cancer BiologybioRxiv
Targeting STAT3 signalling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer
B. M. Simoes, A. Santiago-Gomez, C. Chiodo…·R. B. Clarke
This study shows that SFX-01 reduces CSC activity in ER+ breast cancer by inhibiting STAT3 signaling, improving outcomes in endocrine-resistant models.
DOI 10.1038/s41388-020-1335-z